Introduction
Probiotics are microscopic organisms that benefit their hosts’ health. Probiotics are a type of microorganism that human bodies use to keep themselves healthy. It is beneficial bacteria that are essential in the body system. They help to maintain healthy body systems and control pathogenic microorganisms like germs. Probiotics can help with digestion and nutrient absorption when used correctly. They can be found in fermented foods, cultured milk, and probiotic supplements (Martín & Langella, 2019). There is solid evidence that the gastrointestinal microflora’s composition and metabolic effects are critical for human health. Most probiotics are commensal bacteria that live in the flora of the human gut, protecting it from various diseases. Probiotics work by rebalancing the intestinal flora.
The toxicity and pathogenicity of probiotics are determined by their high cell count and antibiotic resistance. Inflammatory bacteria such as Lactobacillus and Bifidobacterium species are the main constituents in robotics. It is unclear what effect they will have since they produce antimicrobial content. This content fights pathogens, modulates intestinal pH, inhibits bacterial receptors, competes for nutrient absorption, and produces lactase to treat lactose intolerance, allergy risk, immune system strength, and cancer risk (Sanders et al., 2019). Lactobacillus bacteria, for example, have been shown to slow the growth of pathological cells. Slowing this growth boosts the immune system and prevents tumor growth.
Literature: Information Sources
A wealth of information is available on probiotics and intestinal health, covering all aspects of the subject. The information sources include the internet, journals, and books. Scholars and researchers have compiled an extensive database on probiotics and intestinal health. It is a comprehensive concept that applies to various health situations and environments. The information sources have limitations and issues that must be addressed concerning the target population and those affected by the topic.
Probiotics have been extensively researched for their anti-inflammatory and anti-pain properties. There is evidence that probiotics can eliminate toxin receptors, repair hyperpermeable epithelial barriers, fight against infections, and strengthen the immune system. According to Nazemian et al. (2016), it has been shown that probiotics have a significant impact on the expression of cytokines and opioid receptors. Probiotics can aid in the differentiation and activation of immune cells. During this period, anti-inflammatory cytokines and mu-opioid receptors are upregulated, while pro-inflammatory cytokines are downregulated.
Lactobacillus GG is effective in extending infectious diarrhea in children. Clinical trials have shown that probiotics are effective in treating diarrhea (McFarland & Goh, 2019). On the other hand, probiotics appear to reduce antibiotic-associated diarrhea by 60 percent compared to a placebo, according to two comprehensive reviews (McFarland & Goh, 2019). Contrary to popular belief, constipation outnumbers diarrhea in terms of frequency. As a result of increasing bowel movements and softening the stools, probiotics assisted in reducing “gut transit time” by 12.4 hours (Delgado et al., 2020, p. 391). Specific probiotics for constipation are still up in the air, according to the research. Probiotics may also be beneficial for people who have Crohn’s disease or IBS. Several small studies suggest that certain probiotics may aid in the maintenance of remission in ulcerative colitis, the prevention of relapse in Crohn’s disease, and the prevention of intestinal inflammation (Glassner et al., 2020).
Critique
The literature section examines the research activities that were carried out to provide information on the topic, with the actions being classified according to the type of research carried out. The implications of the various research methodologies must imply that they have a significant gap in their ability to meet the diverse framework requirements. A short and quick approach to addressing the concerns about probiotics in the intestinal context is recommended in some of the recommendations based on the analysis findings. Other studies like those (McFarland & Goh 2019) fail to consider reasonable and realistic time frames, which results in more complicated and unachievable situations arising from the given problem. As a result of the reprimanding actions attached to specific aspects of the research analysis and literature, a generalized environment has been created that is detrimental to the implementation of other concepts that are beneficial in mitigating the issues that affect intestinal health as dictated by the probiotics.
The research studies entail a great deal of complex and detailed statistical analysis, all of which provide concise and summarized conclusive statements. As a broad subject, this results in an undesirable situation when comprehensive and extensive information is not provided to meet the needs of different people at all levels of understanding (Taibi & Comelli, 2014). Additionally, recommendations are implied to increase the uptake of a particular product, service, or specific idea. Different contextual situations result in erroneous perceptions because people are coerced into believing false what they are told (McFarland & Goh, 2019). In the case of probiotics, there is a pretext for taking a solution-oriented approach that encourages the use of specific products as solutions to problems, which can be superficial and not substantive enough at other times.
The use of articles, research results, and proposals that recognized institutions and analysts have not reviewed is another situation that is detrimental to using these materials (Kerry et al., 2018). It creates a limited availability of relevant information for developing structural and functional frameworks for comprehensive procedures to design valuable solutions and strategies in probiotics and intestinal health. It also creates structural and functional frameworks for extensive systems (Nazemian et al., 2016). Some studies like that of Glassner et al. (2020) are insufficient and do not address all of the group’s requirements, which leads to and increases bias because the available research information cannot be applied to all of the population sets. Some researchers fail to consider individuals who have health concerns ranging from diseases to minor physical conditions.
In my opinion, probiotics and intestinal health are important at various points in one’s life. They are comprehensive in terms of dealing with problems that arise as a result of health concerns. As a result, more research activities should be conducted. Appropriate policy frameworks should be developed to define how evaluation analysis reduces the issue concerns that imply limitations and adversities in future studies. All necessary analysis points should be covered, and broad principles should be developed to address and reduce the complexities of understanding inferences and other factors.
Conclusion
Both probiotics and anti-inflammatory cytokines can reduce inflammation and symptoms in animals and humans. Probiotics effectively treat inflammatory pain without harming the host, according to the current study. Probiotics reduce inflammation and regulate intestinal flora in autoimmune and inflammatory diseases. As a result of their role in reducing inflammatory pain, probiotics may be analgesics. Using these bacterial compounds regularly may help reduce inflammation, but more research is needed. Probiotics can supplement our diets and meet our clinical needs. Recent research shows distinct probiotic strain functions. It also has properties that make it a portion of good food and a good health supplement. The current focus is on evaluating novel probiotic strains for biomedical/clinical research purposes.
References
Delgado, S., Sánchez, B., Margolles, A., Ruas-Madiedo, P., & Ruiz, L. (2020). Molecules produced by probiotics and intestinal microorganisms with immunomodulatory activity.Nutrients, 12(2), 391. Web.
Glassner, K. L., Abraham, B. P., & Quigley, E. M. (2020). The microbiome and inflammatory bowel disease.Journal of Allergy and Clinical Immunology, 145(1), 16-27. Web.
Kerry, R. G., Patra, J. K., Gouda, S., Park, Y., Shin, H. S., & Das, G. (2018). Benefaction of probiotics for human health: A review.Journal of Food and Drug Analysis, 26(3), 927-939. Web.
Sanders, M. E., Merenstein, D. J., Reid, G., Gibson, G. R., & Rastall, R. A. (2019). Probiotics and prebiotics in intestinal health and disease: from biology to the clinic.Nature Reviews Gastroenterology & Hepatology, 16(10), 605-616. Web.
Martín, R., & Langella, P. (2019). Emerging health concepts in the probiotics field: streamlining the definitions.Frontiers in microbiology, 10, 1047. Web.
McFarland, L. V., & Goh, S. (2019). Are probiotics and prebiotics effective in the prevention of travelers’ diarrhea: a systematic review and meta-analysis.Travel medicine and infectious disease, 27, 11-19. Web.
Nazemian, V., Shadnoush, M., Manaheji, H., & Zaringhalam, J. (2016). Probiotics and inflammatory pain: a literature review study.Middle East Journal of Rehabilitation and Health, 3(2). Web.
Taibi, A., & Comelli, E. M. (2014). Practical approaches to probiotics use.Applied Physiology, Nutrition, and Metabolism, 39(8), 980-986. Web.